Atlas Trials

A Model for Predicting the Efficacy of Conversion Therapy for Patients With Colorectal Cancer Liver Metastases by the Detection of 5-hydroxymethylcytosine (5-hmC) in Plasma Cell-free DNA

Clinical trial NCT03679039 · UNKNOWN

Trial details

NCT number
NCT03679039
Sponsor
Fudan University
Status
UNKNOWN
Study type
OBSERVATIONAL
Colorectal Cancer With Liver Metastases
Start date
2018-09-20
Primary completion
2019-03-31
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.